Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.

am Esch JS 2nd, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, Piechaczek C, Burchardt ER, Feifel N, Stoldt V, Stockschläder M, Stoecklein N, Tustas RY, Eisenberger CF, Peiper M, Häussinger D, Hosch SB.

Stem Cells. 2005 Apr;23(4):463-70.

2.

[Stem cell-induced liver regeneration].

Knoefel WT, Alexander A, Tustas RY, Schmelzle M, Klein HM, Krieg A, Topp SA, Eisenberger CF, Fuerst G, Schulte am Esch J 2nd.

Zentralbl Chir. 2013 Apr;138(2):166-72. doi: 10.1055/s-0031-1271587. Epub 2011 Nov 15. German.

PMID:
22086774
3.

Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience.

Fürst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M, Godehardt E, Krieg A, Wecker B, Stoldt V, Stockschläder M, Eisenberger CF, Mödder U, Knoefel WT.

Radiology. 2007 Apr;243(1):171-9. Epub 2007 Feb 20.

PMID:
17312278
4.

Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study.

am Esch JS, Schmelzle M, Fürst G, Robson SC, Krieg A, Duhme C, Tustas RY, Alexander A, Klein HM, Topp SA, Bode JG, Häussinger D, Eisenberger CF, Knoefel WT.

Ann Surg. 2012 Jan;255(1):79-85. doi: 10.1097/SLA.0b013e31823d7d08.

PMID:
22156926
5.

Autologous CD133+ cells augment the effect of portal embolization.

Canepa MC, Quaretti P, Perotti C, Vercelli A, Rademacher J, Peloso A, Barbieri L, Franchi E, Briani L, Gaspari A, Brugnatelli S, Pedrazzoli P, Dionigi P, Maestri M.

Minerva Chir. 2013 Apr;68(2):163-8.

PMID:
23612229
6.

Infusion of CD133+ Bone Marrow-derived Stem Cell After Selective Portal Vein Embolization Enhances Functional Hepatic Reserves After Extended Right Hepatectomy.

Lim C, Audollent R, Pocard M, Azoulay D.

Ann Surg. 2016 Mar;263(3):e44-5. doi: 10.1097/SLA.0000000000000404. No abstract available.

PMID:
24263310
7.

Reply to Letter: "Infusion of CD133+ Bone Marrow-Derived Stem Cell After Selective Portal Vein Embolization Enhances Functional Hepatic Reserves After Extended Right Hepatectomy".

Schulte am Esch J, Schmelzle M, Duhme C, Fuerst G, Robson SC, Bode JG, Krieg A, Topp SA, Haeussinger D, Knoefel WT.

Ann Surg. 2016 Mar;263(3):e44-5. doi: 10.1097/SLA.0000000000000849. No abstract available.

8.

Two-stage hepatectomy after autologous CD133+ stem cells administration: a case report.

Franchi E, Canepa MC, Peloso A, Barbieri L, Briani L, Panyor G, Dionigi P, Maestri M.

World J Surg Oncol. 2013 Aug 13;11(1):192. doi: 10.1186/1477-7819-11-192.

9.

HGF and SDF-1-mediated mobilization of CD133+ BMSC for hepatic regeneration following extensive liver resection.

Lehwald N, Duhme C, Wildner M, Kuhn S, Fürst G, Forbes SJ, Jonas S, Robson SC, Knoefel WT, Schmelzle M, Schulte Am Esch J.

Liver Int. 2014 Jan;34(1):89-101. doi: 10.1111/liv.12195. Epub 2013 May 23.

PMID:
23701640
10.

Predictive Value of Growth Factors and Interleukins for Future Liver Remnant Volume and Colorectal Liver Metastasis Volume Growth Following Portal Vein Embolization and Autologous Stem Cell Application.

Fichtl J, Treska V, Lysak D, Mirka H, Duras P, Karlikova M, Skalicky T, Vodička J, Topolcan O.

Anticancer Res. 2016 Apr;36(4):1901-7.

PMID:
27069178
11.

What is the role of bone marrow-derived stem cells in hepatic hypertrophy after portal vein embolization?

Zaydfudim VM, Smoot RL, Nagorney DM.

Ann Surg. 2015 Jan;261(1):e25-6. doi: 10.1097/SLA.0000000000000423. No abstract available.

PMID:
24368660
12.

Autologous bone marrow-derived mesenchymal stem cell transplantation promotes liver regeneration after portal vein embolization in cirrhotic rats.

Li T, Zhu J, Ma K, Liu N, Feng K, Li X, Wang S, Bie P.

J Surg Res. 2013 Oct;184(2):1161-73. doi: 10.1016/j.jss.2013.04.054. Epub 2013 May 16.

PMID:
23809154
13.

Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis.

Nikeghbalian S, Pournasr B, Aghdami N, Rasekhi A, Geramizadeh B, Hosseini Asl SM, Ramzi M, Kakaei F, Namiri M, Malekzadeh R, Vosough Dizaj A, Malek-Hosseini SA, Baharvand H.

Arch Iran Med. 2011 Jan;14(1):12-7. doi: 011141/AIM.004.

14.

Portal vein embolisation with application of haematopoietic stem cells in patients with primarily or non-resectable colorectal liver metastases.

Treska V, Liska V, Fichtl J, Lysak D, Mirka H, Bruha J, Duras P, Treskova I, Nahlik J, Simanek V, Topolcan O.

Anticancer Res. 2014 Dec;34(12):7279-85.

PMID:
25503161
15.

Portal vein embolization and stem cell administration.

Ozkan F, Peynircioglu B, Cil BE.

Radiology. 2008 Feb;246(2):646; author reply 646-7. doi: 10.1148/radiol.2462070523. No abstract available.

PMID:
18227559
16.

Autologous stem cell transplantation for expansion of remnant liver volume with extensive hepatectomy.

Han HS, Ahn KS, Cho JY, Yoon YS, Yoon CJ, Park KU, Min SK, Lee HK, Ryu KH.

Hepatogastroenterology. 2014 Jan-Feb;61(129):156-61.

PMID:
24895813
17.

Safety analysis and improved cardiac function following local autologous transplantation of CD133(+) enriched bone marrow cells after myocardial infarction.

Ahmadi H, Baharvand H, Ashtiani SK, Soleimani M, Sadeghian H, Ardekani JM, Mehrjerdi NZ, Kouhkan A, Namiri M, Madani-Civi M, Fattahi F, Shahverdi A, Dizaji AV.

Curr Neurovasc Res. 2007 Aug;4(3):153-60.

PMID:
17691968
18.

Sequential preoperative ipsilateral hepatic vein embolization after portal vein embolization to induce further liver regeneration in patients with hepatobiliary malignancy.

Hwang S, Lee SG, Ko GY, Kim BS, Sung KB, Kim MH, Lee SK, Hong HN.

Ann Surg. 2009 Apr;249(4):608-16. doi: 10.1097/SLA.0b013e31819ecc5c.

PMID:
19300228
20.

Supplemental Content

Support Center